Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Analysis of metabolic profiles in urine in urinary bladder cancer

2012/05/B/NZ7/03293

Keywords:

metabolomics biomarkers urinary bladder cancer CE-LIF-TOF LC-LIF-TOF LC-MS/MS urine

Descriptors:

  • NZ2_4: Metabolomics

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

woj. pomorskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr hab. Michał Markuszewski 

Number of co-investigators in the project: 7

Call: OPUS 3 - announced on 2012-03-15

Amount awarded: 873 571 PLN

Project start date (Y-m-d): 2013-02-13

Project end date (Y-m-d): 2016-08-12

Project duration:: 42 months (the same as in the proposal)

Project status: Project settled

Equipment purchased [PL]

  1. Elektroforeza kapilarna sprzężona z detektorem laserowo wzbudzanej fluorescencji (CE-LIF) (467 971 PLN)

Information in the final report

  • Publication in academic press/journals (6)
  1. Determination of pterins in urine by HPLC with UV and fluoroscent detection using different types of chromatographic stationary phases (HILIC, RP C8, RP C18)
    Authors:
    Kośliński P., Jarzemski P., Markuszewski M.J., Kaliszan R.
    Academic press:
    Journal of Pharmaceutical and Biomedical Analysis (rok: 2014, tom: 91, strony: 37-45), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.pba.2013.12.012 - link to the publication
  2. Metabolomic heterogeneity of urogenital tract cancers analyzed by complementary chromatographic techniques coupled with mass spectrometry
    Authors:
    Arlette Yumba Mpanga, Wiktoria Struck-Lewicka, Renata Bujak, Marcin Markuszewski, Marek Roslan, Roman Kaliszan, Michał Jan Markuszewski
    Academic press:
    Current Medicinal Chemistry (rok: 2018, tom: 25, strony: 45307), Wydawca: BENTHAM SCIENCE PUBL LTD
    Status:
    Published
    DOI:
    10.2174/0929867324666171006150326. - link to the publication
  3. Analysis of urinary nucleosides as potential cancer markers determined using LC--MS technique
    Authors:
    Struck-Lewicka W., Kaliszan R., Markuszewski M.J.
    Academic press:
    Journal of Pharmaceutical and Biomedical Analysis (rok: 2014, tom: 101, strony: 50-57), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.jpba.2014.04.022 - link to the publication
  4. Statistical-based approach in potential diagnostic application of urinary nucleosides in urogenital tract cancer
    Authors:
    Emilia Daghir-Wojtkowiak, Wiktoria Struck-Lewicka, Malgorzata Waszczuk-Jankowska, Marcin Markuszewski, Roman Kaliszan, Michal Jan Markuszewski
    Academic press:
    Biomarkers in Medicine (rok: 2015, tom: 9, strony: 577-595), Wydawca: Future Medicine Ltd
    Status:
    Published
    DOI:
    10.2217/bmm.15.20 - link to the publication
  5. Metabolomics for laboratory diagnostics
    Authors:
    Renata Bujak, Wiktoria Struck-Lewicka, Michał J. Markuszewski, Roman Kaliszan
    Academic press:
    Journal of Pharmaceutical and Biomedical Analysis (rok: 2015, tom: 113, strony: 108-120), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.jpba.2014.12.017 - link to the publication
  6. The metabolic profiles of pterin compounds as potential biomarkersof bladder cancer—Integration of analytical-based approach withbiostatistical methodology
    Authors:
    Piotr Kośliński, Emilia Daghir-Wojtkowiab, Paulina Szatkowska-Wanda, Marcin Markuszewski, Michał J. Markuszewski
    Academic press:
    Journal of Pharmaceutical and Biomedical Analysis (rok: 2016, tom: 127, strony: 256–262), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.jpba.2016.02.038 - link to the publication